About UsThe University of Michigan Pancreatic Cancer Center was established in 2012 and is dedicated to the mission of helping improve the lives of patients with pancreatic cancer by expanding the scientific knowledge about the disease.
Diane M. Simeone, M.D.
Diane M. Simeone, M.D., is the founding director of the University of Michigan Pancreatic Cancer Center. She also serves as the Surgical
Director for the University of Michigan Multidisciplinary Pancreatic Tumor Program, and Director of the
Comprehensive Cancer Center Gastrointestinal (GI) Oncology Program.
Lazar J. Greenfield Professor of Surgery and of
Molecular and Integrative Physiology
Director, Multidisciplinary Pancreatic Tumor Program
Director, Translational Oncology Program (TOP)
Director, Pancreatic Cancer Center
Dr. Simeone received her bachelor's degree from Brown University in Providence, Rhode Island and a medical degree from Duke University Medical School in Durham, North Carolina. She completed her General Surgery residency training in 1995 at the University of Michigan Medical Center. She joined the faculty at the University of Michigan Medical Center in 1995.
Dr. Simeone is an active clinician and participates in every aspect of the clinic, including clinical trials. She is distinguished as an expert on pancreatic cancer, and her primary focus is patient care. Her basic science laboratory investigates the mechanisms of pancreatic growth regulation and molecular events important in the development and progression of pancreatic adenocarcinoma.
Dr. Simeone is an associate member of the Early Detection Research Network (EDRN), an NCI-funded initiative to identify and validate early detection biomarkers for the diagnosis of pancreatic cancer, serves on the Scientific Advisory Board of the Pancreatic Cancer Action Network (PANCAN), and is a member of the Institute of Medicine.
Michelle A. Anderson, M.D., M.Sc.
Michelle A. Anderson, M.D., M.Sc., completed her Internal Medicine residency and Gastroenterology fellowship at the University of Michigan where she
trained in advanced endoscopy including endoscopic ultrasound and ERCP.
Co-Director of the University of Michigan Pancreatic Cancer Center
Following fellowship training, she joined the faculty at Michigan. Dr. Anderson's clinical and research interests focus on diseases of the pancreas and biliary system with a special emphasis on chronic pancreatitis, pancreatic cancer and therapeutic EUS and ERCP as they relate to these diseases.
In 2005, she received a Master of Science degree in Clinical Research and Statistical Analysis from the University of Michigan's School of Public Health. With funding from the NIH, Dr. Anderson combines her clinical and research training to conduct research to identify biomarkers to distinguish pancreatic cancer from chronic pancreatitis. She performs EUS and ERCP in clinical practice as well as in teaching forums both nationally and internationally.
She is an active member of the American Society of Gastrointestinal Endoscopy (ASGE), the American Gastroenterological Association and the American College of Gastroenterology. Dr. Anderson is a Fellow of the ASGE and has served on the ASGE Standards of Practice Committee and the ASGE Institute for Training and Technology for almost 10 years.
Max S. Wicha, M.D.
As founding director of the University of Michigan Comprehensive Cancer Center, Max S. Wicha, M.D., is responsible for coordinating all cancer
activities related to research and patient care.
Director, U-M Comprehensive Cancer Center
Dr. Wicha also serves as the distinguished professor of oncology, professor of internal medicine and is nationally known for his research in the field of breast oncology, particularly the study of how breast cancer cells grow and metastasize. His lab was part of the team that first discovered stem cells in breast cancer, the first described in any human solid tumor.
Since then, Dr. Wicha has become one of the leading experts on cancer stem cells, with his continued work on breast cancer stem cells. He has also led efforts within the UMCCC to expand these findings into other tumor types. U-M researchers were first to discover stem cells in pancreatic and head and neck cancers and are focusing on cancer stem cells in virtually every cancer type, including colon, lung and thyroid tumors.
Dr. Wicha is also active as a clinician, specializing in the treatment of breast cancer patients. He has served as chairman of the board of the Association of American Cancer Institutes and as past chairman for the National Cancer Institute's Cancer Center Support Review Committee.
Dr. Wicha joined the University of Michigan Medical Center in 1980. From 1984 to 1993, he served as chief in the Division of Hematology/Oncology in the Department of Internal Medicine. Dr. Wicha received his medical degree from Stanford University and trained in internal medicine at the University of Chicago. He then went on to the National Cancer Institute, where he trained in clinical oncology and cancer biology.